GSK shares jump after Tk 16bn Unilever deal
Shares of GlaxoSmithKline Bangladesh jumped on Tuesday, buoyed by the news that it sold its business to Unilever.
The GSK stock rose 6.25 percent to Tk 1,457.8, the highest since May 10 on the Dhaka Stock Exchange.
The Bangladesh deal is part of Unilever’s agreement to pay €3.3 billion for GlaxoSmithKline’s consumer nutrition business, expanding its footprint in India with the popular hot malted beverage Horlicks.
The deal is likely to be the last major mark left on the Anglo-Dutch giant by its veteran chief executive Paul Polman before he retires in January. Unilever fought off competition from rival Nestlé and Coca-Cola to win the auction.
It will fund the acquisition largely through shares of its listed India subsidiary Hindustan Unilever and limit the cash outlay to about €639 million.
Source: https://bdnews24.com
Tags :
Previous Story
- Net foreign investment at DSE negative in November
- Dhaka stocks rise sharply as financial scrips soar
- Bangladesh flower market reaches Tk1,200cr, expanding at 10%...
- Camellia Profit To Rise On New Bangladeshi Tea...
- Unilever to buy 82pc of GSK Bangladesh
- Delisting acts as wake-up call for Rahima Food
- Stocks open week upward on large-cap vibe
- Dhaka stocks inch up amid pre-elections jitters